WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H124687
CAS#: 7134-11-4
Description: Potassium guaiacolsulfonate also known as sulfoguaiacolum is a salt of GUAIACOLSULFONIC ACID, which is used as an expectorant, to relieve symptoms of cough and mucus in the chest due to respiratory infections, asthma, colds, or hay fever.
Hodoodo Cat#: H124687
Name: Sulfogaiacol
CAS#: 7134-11-4
Chemical Formula: C7H8O5S
Exact Mass: 204.01
Molecular Weight: 204.200
Elemental Analysis: C, 41.17; H, 3.95; O, 39.18; S, 15.70
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: Potassium guaiacolsulfonate; Sulfogaiacol; Guaiacolsulfonic acid; Guaiacolsulfonate; Guajacol-5-sulfosaure
IUPAC/Chemical Name: 4-hydroxy-3-methoxybenzenesulfonic acid
InChi Key: QDRCGSIKAHSALR-UHFFFAOYSA-N
InChi Code: InChI=1S/C7H8O5S/c1-12-7-4-5(13(9,10)11)2-3-6(7)8/h2-4,8H,1H3,(H,9,10,11)
SMILES Code: COC1=C(C=CC(=C1)S(=O)(=O)O)O
Appearance: To be determined
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 204.20 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Revol B, Doudoux HM, Sam-Laï NF, Mallaret M. Convulsions associées à l’abus
de Néocodion® (camphosulfonate de codéine, sulfogaïacol, extrait de
grindélia) [Convulsions associated with Neocodion® abuse (codeine
camphosulfonate, sulfogaiacol, grindelia extract)]. Therapie. 2017
Dec;72(6):699-700. French. doi: 10.1016/j.therap.2017.05.002. Epub 2017 Jul 16.
PMID: 28800836.
2: Armand C, Thirion X, Saillard C, Lapeyre-Mestre M, Lambert H. 10 ans de
détournement d'usage du Néocodion entre 1992 et 2002 [Neocodion misuse:
evolution between 1992 and 2002]. Therapie. 2004 Sep-Oct;59(5):547-53. French.
doi: 10.2515/therapie:2004093. PMID: 15648308.